药学前沿大讲堂第256讲

题目: English Writing in Biomedical Research for Publications

报告人: 叶冀明教授，澳大利亚皇家墨尔本理工大学

主持人: 黄志纾教授，bm11222宝马娱乐网站

时间: 2016年9月3日（周六）9:30-12:00

地点: 中山大学东校区行政楼B101

报告人简介:

Prof. Jiming Ye has a research career for over 30 years after his medical training and a Master degree in China. He obtained his PhD degree in the University of Tasmania in Australia with Prof Michael Clark in vascular control of energy metabolism. He was a NHMRC Senior Research Officer with Prof Edward Kraegen at Garvan Institute (Australia) between 1997 and 2003. After one year of clinical trials in Eli Lilly, he returned to Garvan Institute in 2005 leading the research of drug discovery for diabetes and was a conjoint Assoc Prof of the University of NSW (2008-2013). In 2010, he joined RMIT University as an Assoc Prof and established the Molecular Pharmacology for Diabetes Laboratory. Since 2012, he has been a Professor for Ageing and Chronic Disease Management. Prof Ye’s research focuses on two fundamental areas in Type 2 diabetes and fatty liver disease: molecular mechanisms of these metabolic disorders and novel therapeutic approaches for the related diseases. His investigation of the molecular mechanisms focuses on the roles of fatty acid oxidation and synthesis, mitochondrial dysfunction, ER stress and autophagy in the development of insulin resistance and fatty liver disease. Based on identified targets (incl. AMPK, SIRT, FoxO1, HSP72 and epigenetic regulations), his lab conducts research in drug discovery and molecular pharmacology for type 2 diabetes and fatty liver disease. Prof Ye has published >90 peer-reviewed research papers > 4600 total citations and 4 patents. He has expertise in insulin resistant cell/animal models, tracer techniques, biochemical assays, signalling pathways and gene expression for metabolic studies. His current research interests include: 1) Nutrition compositions and metabolic disease, 2) Type 2 diabetes, lipid biology and insulin resistance, 3) Mitochondrial dysfunction, ER stress and autophagy, 4) Metabolic memory and epigenetic regulation, and 5) Drug discovery and molecular pharmacology. Currently, Prof Ye is the Director of the Metabolism, Exercise and Disease Program of 18 research groups. He also leads RMIT’s collaborations with Sun Yat-sen University, Shanghai Institute of Materia Medica and South China University of Technology.

欢迎广大师生踊跃参与！